HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jones, P. Articles by Higenbottam, T. Search for Related Content PubMed PubMed Citation Articles by Jones, P. Articles by Higenbottam, T.

Quantifying of Severity of Exacerbations in Chronic Obstructive Pulmonary Disease

Adaptations to the Definition to Allow Quantification

¹ St. George's, University of London, London, United Kingdom; and ² AstraZeneca R&D, Charnwood, Loughborough, United Kingdom

Correspondence and requests for reprints should be addressed to Paul Jones, Ph.D., F.R.C.P., St. George's, University of London, Cranmer Terrace, London, SW17 0RE, UK. E-mail: pjones{at}sgul.ac.uk

ABSTRACT

Exacerbations of chronic obstructive pulmonary disease (COPD) offer a considerable clinical challenge for clinical practice and drug development. The underlying pathobiology of these characteristic events is unclear. We are far behind other disease areas, such as cardiology, where there are effective approaches for diagnosing and managing acute and potentially fatal events. A joint initiative has begun between the pharmaceutical industry, academia, and the Food and Drug Administration to produce a valid diary card measure of exacerbation severity: the EXAcerbations of Chronic pulmonary disease Test–Patient-Reported Outcome (EXACT-PRO). This article describes the background to this initiative, using the consensus definition of a COPD exacerbation as the starting point from which to propose a new method for quantifying the severity of the event. This approach takes into account the relationships between the symptoms that make up an exacerbation and shows that they can be used in a single continuous severity scale. Methods for defining exacerbation onset and cessation are also proposed.

Key Words: exacerbations • diary card • symptoms • patient-reported outcomes

This article has been cited by other articles:

				T. W. Effing, H. A. M. Kerstjens, E. M. Monninkhof, P. D. L. P. M. van der Valk, E. F. M. Wouters, D. S. Postma, G. A. Zielhuis, and J. van der Palen Definitions of Exacerbations: Does It Really Matter in Clinical Trials on COPD? Chest, September 1, 2009; 136(3): 918 - 923. [Abstract] [Full Text] [PDF]